Jeff Yass’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-42,200
| Closed | -$80K | – | 14420 |
|
|
2021
Q4 | $80K | Sell |
42,200
-12,800
| -23% | -$30.7K | ﹤0.01% | 12292 |
|
|
2021
Q3 | $166K | Buy |
55,000
+12,700
| +30% | +$45.2K | ﹤0.01% | 11703 |
|
|
2021
Q2 | $165K | Sell |
42,300
-44,100
| -51% | -$183K | ﹤0.01% | 11787 |
|
|
2021
Q1 | $438K | Buy |
86,400
+71,100
| +465% | +$369K | ﹤0.01% | 9781 |
|
|
2020
Q4 | $63K | Sell |
15,300
-8,300
| -35% | -$40.8K | ﹤0.01% | 10686 |
|
|
2020
Q3 | $115K | Buy |
+23,600
| New | +$129K | ﹤0.01% | 9835 |
|
|
2020
Q2 | – | Sell |
-16,800
| Closed | -$55K | – | 11230 |
|
|
2020
Q1 | $55K | Buy |
+16,800
| New | +$88.5K | ﹤0.01% | 9649 |
|
|
2017
Q4 | – | Sell |
-26,700
| Closed | -$105K | – | 10113 |
|
|
2017
Q3 | $105K | Buy |
26,700
+9,000
| +51% | +$41.3K | ﹤0.01% | 8342 |
|
|
2017
Q2 | $90K | Sell |
17,700
-8,400
| -32% | -$47.2K | ﹤0.01% | 8728 |
|
|
2017
Q1 | $180K | Buy |
26,100
+14,800
| +131% | +$116K | ﹤0.01% | 8090 |
|
|
2016
Q4 | $106K | Buy |
+11,300
| New | +$102K | ﹤0.01% | 9058 |
|
Jeff Yass's AGTC Position: Q4 2022 in Review
Jeff Yass sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,512 shares — an estimated $6K sold.
Jeff Yass first reported a position in AGTC in Q4 2016 and held it in 14 quarters. The position peaked at $797K in Q2 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Jeff Yass reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Jeff Yass sold 20,512 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $6K.
- Jeff Yass first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 14 quarters.
- Jeff Yass's Applied Genetic Technologies Corporation position peaked at $797K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.